Informed-money record

LYEL · Lyell Immunopharma, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

2

Bearish filings

30

Named actors

8

Disclosed $ (bull / bear)

$25.0M / $527K

Recent disclosures

25 of 32 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-06-10Chief Medical Officer Shook Davidsold$25KSEC ↗
2026-05-11President and CEO Seely Lynnsold$7KSEC ↗
2026-05-11Chief Operating Officer Hill Stephen J.sold$2KSEC ↗
2026-05-11Chief Scientific Officer Lee Gary K.sold$2KSEC ↗
2026-05-11VP, Corporate Controller Bulis Veronica Sanchezsold$4KSEC ↗
2026-03-0610% owner / other BERNS PAUL Lbought$12.5MSEC ↗
2026-03-0610% owner / other ARCH Venture Partners IX Overage, L.P.bought$12.5MSEC ↗
2026-02-11President and CEO Seely Lynnsold$174KSEC ↗
2026-02-11Chief Operating Officer Hill Stephen J.sold$29KSEC ↗
2026-02-11Chief Scientific Officer Lee Gary K.sold$39KSEC ↗
2026-02-10President and CEO Seely Lynnsold$10KSEC ↗
2026-02-10Chief Operating Officer Hill Stephen J.sold$3KSEC ↗
2026-02-10Chief Scientific Officer Lee Gary K.sold$3KSEC ↗
2026-02-10VP, Corporate Controller Bulis Veronica Sanchezsold$6KSEC ↗
2025-12-30VP, Corporate Controller Bulis Veronica Sanchezsold$30KSEC ↗
2025-12-24VP, Corporate Controller Bulis Veronica Sanchezsold$44KSEC ↗
2025-11-10President and CEO Seely Lynnsold$7KSEC ↗
2025-11-10Chief Operating Officer Hill Stephen J.sold$2KSEC ↗
2025-11-10Chief Scientific Officer Lee Gary K.sold$2KSEC ↗
2025-11-10VP, Corporate Controller Bulis Veronica Sanchezsold$4KSEC ↗
2025-08-21Chief Scientific Officer Lee Gary K.sold$15KSEC ↗
2025-08-21Chief Financial Officer Newton Charles W.sold$15KSEC ↗
2025-08-21Chief Operating Officer Hill Stephen J.sold$11KSEC ↗
2025-08-21President and CEO Seely Lynnsold$76KSEC ↗
2025-08-12Chief Financial Officer Newton Charles W.sold$1KSEC ↗

7 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals